Responsible Editor: Asim Duttaroy, Oslo University, Norway.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
These studies were designed to assess whether wheat polyphenols (mainly ferulic acid [FA]) increased the very-long-chain omega-3 fatty acids (VLC n-3) [eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)] in rats. Wheat aleurone (WA) was used as a dietary source of wheat polyphenols. Two experiments were performed; in the first one, the rats were fed WA or control pellets (CP) in presence of linseed oil (LO) to provide alpha-linolenic acid (ALA), the precursor of VLC n-3. In the second one, the rats were fed WA or CP in presence of control oil (CO) without ALA. The concentrations of phenolic acid metabolites in urine were also investigated.
The urinary concentration of conjugated FA increased with WA ingestion (
These results suggest that WA consumption has a significant effect on EPA in plasma without affecting n-6. Subsequent studies are required to examine whether these effects may explain partly the health benefits associated with whole wheat consumption.
Clinical and epidemiological studies suggest that whole-grain consumption is associated with beneficial health effects (
The rats were cared for in accordance with the European Council Directive 86/609/EEC on the care and use of laboratory animals (OJ L 358). The protocols were performed under license from the French Ministry of Agriculture (license no. A380727) and approved by the local animal ethics committee (license n°113_ LBFA-FO-01).
Forty-eight male Wistar rats (Charles River Laboratories, baseline body weight 75–100 g) were fed a standard diet (A04, SAFE Diets, France). The animals were acclimated 1 week before being distributed into the four experimental groups (
Study design.
In experiment 1 (Exp. 1), the rats (
In experiment 2 (Exp. 2), the rats (
Both CO and LO were provided by gavage and brought 9 kcal/g. The amount of fat provided by the oils was adjusted to the recommendations of the American Institute of Nutrition Rodent Diets-93 (
The WA pellets provided, in addition to the standard diet, a total of 53.4 mg of FA per day and per rat. The CP were prepared by mixing 1 g of standard A04 ground in flour with 2.5 mL water and 12.5 mg refined commercial white sugar. Mass density of 1 g of the flour of standard A04 was equivalent to 2 g of the WA layer flour. The CP provided, in addition to the standard diet, a total of 8.4 mg of FA per day and per rat. The WA and CP were prepared daily.
Macronutrient and fatty acid composition of A04 diet and wheat aleurone
| A04 diet (SAFE) | Wheat aleurone | |
|---|---|---|
| g/100 g | ||
|
|
||
| Proteins | 16.1 | 12.6 |
| Total carbohydrates | 59.9 | 61.8 |
| Lipids | 3.1 | 8.7 |
| Fatty acids | mg/100 g lipid | |
|
|
||
| Saturated fatty acids | 620 | 955 |
| C18:1n-9 | 400 | 1,211 |
| C18:2n-6 | 1,310 | 3,240 |
| C18:3n-3 | 110 | 326 |
| C20:4n-6 | 0.0 | 0.6 |
| C20:5n-3(eicosapentaenoic acid) | 20 | 12 |
| C22:5n-3 | 10 | 11 |
| C22:6n-3(docosahexaenoic acid) | 30 | 1.2 |
In all the experiments body weights and food consumption were recorded weekly. At the end of Exp. 1 and 2, blood was collected on fasted rats and plasma was stored at −80°C. Immediately after blood collection, the rats were euthanized and their liver sampled, weighed, frozen in liquid nitrogen, and stored at −80°C until analysis. Finally, the urinary concentration of phenolic acids and their metabolites was estimated in the urine samples collected overnight during the last week of treatment of the animals in Exp. 1.
Plasma and liver lipids were extracted in hexane/isopropanol as described (
Phenolic acids in CP and WA, as well as phenolic metabolites in rat urine, were analyzed using an Accela UHPLC 1250 equipped with a linear ion-trap-mass spectrometer (LTQ XL, Thermo Fisher Scientific Inc., San Jose, CA, USA) fitted with a heated-electrospray ionization probe (H-ESI-II; Thermo Fisher Scientific Inc.). Separations were performed using a BlueOrchid-1.8 C18 column (50×2 mm) (Knauer, Berlin, Germany). Pure helium gas (99.999%) was used for collision-induced dissociation (CID). The HPLC-MSn conditions used for the detection are available in the
For the extraction of the free phenolic fraction, 500 mg of sample were mixed with 6 mL of water. The sample was mixed for 2 min, left under agitation for 30 min at room temperature, and centrifuged at 9,200×
Urine samples of rats treated with CP or WA were filtered through a 0.45 µm nylon filter before UHPLC-MSn analysis. The HPLC-MSn conditions used for the detection are available in the
Statistics were realized using the software Minitab version 15 (GrimmerSoft, Paris, France). The difference between each fatty acid was compared with unpaired Student's
In Exp. 1, body weight after 12 weeks (373±26 g vs. 367±13 g) and food intake (23.8±2.6 g/day vs. 22.1±1.4 g/day) were not different in the two groups. In Exp. 2, body weight after 12 weeks (376±23 g vs. 378±21 g) and food intake (24.1±1.0 g/day vs. 23.3±1.3 g/day) were not different in the two groups.
Several phenolic acids have been identified and quantified in the WA and CP pellets. The sum of phenolic acids was 28 mg/g for WA and 10 mg/g for CP, mostly in bound form (
Phenolic acid content in WA and CPa
| WA, |
CP, |
|||
|---|---|---|---|---|
|
|
||||
|
|
||||
| Free | Bound | Free | Bound | |
|
|
||||
| Compounds, mg/g of diet | ||||
|
|
||||
| p-Hydroxybenzoic acid | 0.12±0.02 | ND | ND | ND |
| p-Coumaric acid | 0.29±0.02 | 0.70±0.07 | 0.07±0.01 | 1.1±0.06 |
| Caffeic acid | ND | 0.04±0.00 | ND | 0.07±0.00 |
| Trans-ferulic acid | 0.31±0.06 | 8.9±0.63 | 0.06±0.01 | 3.3±0.34 |
| Ferulic acid isomer | ND | 2.8±0.44 | ND | 1.1±0.25 |
| Sinapic acid | ND | 0.17±0.02 | ND | 0.11±0.03 |
| Sinapic acid isomer | ND | 0.04±0.01 | ND | 0.04±0.00 |
| Dimeric ferulic acids | ND | 13.5±2.2 | ND | 3.6±0.23 |
| Trimeric ferulic acids | ND | 1.2±0.00 | ND | 0.33±0.03 |
aEach value is mean±SD.
WA=wheat aleurone pellets, CP=control pellets, ND=not detected.
Several phenolic acid metabolites have been identified in the urines of rats receiving either CP or WA (
Urinary concentration of main phenolic acid metabolites in rats fed WA and CPa
| WA, |
CP, |
|
|||
|---|---|---|---|---|---|
|
|
|||||
| Compounds, µmol/L | |||||
|
|
|||||
| Hydroxyphenylpropionic acid-like | 36.95±29.2 | 13.40±2.1 | NS | ||
| Hippuric acid | 2,031±506.9 | 1,361±258.8 | NS | ||
| Hydroxyphenylpropionic acid- |
52.23±25.1 | 27.95±3.3 | NS | ||
|
|
|
|
|
||
| Dihydroferulic acid- |
16.04±7.8 | 5.70±2.7 | NS | ||
| Enterolactone- |
43.83±30.3 | 13.13±5.1 | NS | ||
aValues are means±SD,
NS=non-significant (
WA=wheat aleurone pellets, CP=control pellets. Hydroxyphenylpropionic acid-like, 3′-Hydroxyphenylpropionic acid, Methoxyhydroxybenzoic acid-O-sulfate and Ferulic acid-O-glucuronide were also analysed but not reported in the table.
In Exp. 1 with CO, cholesterol and triglycerides were not different in the two groups (
Effect of WA on plasma lipids and fatty acids in rats receiving the control or the linseed oilsa
| Experiment 1 | Experiment 2 | |||
|---|---|---|---|---|
|
|
||||
|
|
||||
| CP, |
WA, |
CP, |
WA, |
|
|
|
||||
| Lipids, mmol/L | ||||
| Total cholesterol | 0.53±0.07 | 0.55±0.13 | 0.57±0.10 | 0.50±0.06 |
| Triglycerides | 0.84±0.30 | 0.74±0.15 | 0.90±0.29 | 0.83±0.25 |
| Fatty acids,% of total fatty acids | ||||
| C14:0 | 0.27±0.06 | 0.27±0.05 | 0.28±0.08 | 0.28±0.11 |
| C16:0 | 18.8±1.5 | 18.7±1.7 | 17.7±1.1 | 17.5±1.5 |
| C18:0 | 7.4±0.93 | 6.7±0.80 | 6.9±0.90 | 6.6±1.2 |
| C18:1n-9 | 9.6±2.4 | 10.0±2.7 | 9.3±2.45 | 8.7±1.81 |
| C18:2n-6 | 23.1±1.4 | 24.1±1.4 | 26.0±1.1 | 26.5±1.1 |
| C18:3n-3 | 0.75±0.12 | 0.85±0.22 | 2.8±0.49 | 2.9±0.49 |
| C20:4n-6 | 26.8±5.1 | 25.6±4.9 | 21.1±4.4 | 21.2±4.2 |
| C20:5n-3 (EPA) |
|
|
4.0±0.69 | 4.1±0.70 |
| C22:4n-6 | 0.29±0.04 | 0.25±0.04 | 0.18±0.03 | 0.16±0.03 |
| C22:5n-3 | 0.78±0.14 | 0.79±0.09 | 1.3±0.32 | 1.4±0.33 |
| C22:6n-3 (DHA) | 4.8±0.41 | 4.6±0.42 | 4.8±0.75 | 4.8±0.67 |
| Total | 100.0 | 100.0 | 100.0 | 100.0 |
aValues are means±SD,
*
The main aims of this study were to test whether WA polyphenols may influence the metabolism of VLC n-3 as shown with some other polyphenols in animals and humans (
The significant concentration of FA-
In Exp. 1, plasma EPA increased by 25% compared to controls which confirms that some polyphenols can be involved in the metabolism of VLC n-3 in the absence of effect on n-6. Indeed, previous studies in humans suggested that wine polyphenols may increase plasma and tissue levels of EPA and DHA (
We found no difference between groups in the liver fatty acids. These results were quite surprising because the liver is thought to play a central role in the synthesis of EPA (and eventually DHA) from ALA. The difference between liver and plasma in the effect of WA polyphenols on VLC n-3 suggests a mechanism other than stimulation of the n-3 pathway mainly in the liver. For instance, the implication of the gut microbiota can be suspected in accordance with a recent study in growing gilts fed flax-seed containing diet (
In Exp. 2, we tested whether increased ALA (under the form of LO) intake can stimulate the synthesis of EPA compared with a CO not containing any ALA. Contrary to our expectations, WA had no effect on EPA in presence of dietary ALA.
Two explanations could be proposed. If the gut microbiota is really involved in the synthesis of EPA from ALA, it could be speculated that high ALA intake may have inhibited the growth of some specific bacteria in the gut (
Subsequent studies are needed to evaluate the dose-effect, or whether there is a threshold effect, in the relation between WA and the n-3 pathway. Also it is not clear whether longer exposition to WA polyphenols may influence the effects on VLC n-3. The low bioavailability of FA provided by aleurone can be also a limitation to this study. Finally, the biological mechanisms involved in the effect of the polyphenols on VLC n-3 are not elucidated yet. More investigations on the PUFA gene expression pathways and transcription factors are needed, and the role of the gut microbiota is still unclear.
In conclusion, our data show that WA and probably the polyphenols present in WA interferes with the metabolism of VLC n-3 without affecting the metabolism of n-6. Although the exact mechanisms are not clearly identified, our results provide new insights into the health benefits of polyphenol-rich whole grains.
The authors acknowledge C. Tellier for care of the animals, and M. Tripier-Champ and Y. Maffren for the technical assistance.
This project has been funded by Barilla G. R. Fratelli Spa and supported in part by the 7th Framework Program ATHENA (Grant agreement no.: 245121) from the European Community. Ounnas, Privé, Hazane-Puch, Laporte, Del Rio, Calani and Demeilliers have no conflicts of interest. Salen and de Lorgeril disclose receiving research grant (through Grenoble University School of Medicine) from the Barilla G&R F.lli Company. Melegari and Bianchi are employees of Barilla G. R. Fratelli Spa.
CD and MdeL contributed equally to this work as senior investigators